For older people and frail people, the long-term benefit of medicines reduces and the potential for harm from adverse effects increases. When the benefit–risk balance changes in this way, medicine review and optimisation are important to simplify the therapeutic regimen, reduce inappropriate medicines and minimise risks. In this article, pharmacist prescriber Linda Bryant uses two case studies to illustrate important considerations during medicine reviews
Consider deprescribing medications in frail, older people when risks exceed benefits
+News
In print
Summer Hiatus
Consider deprescribing medications in frail, older people when risks exceed benefits
Wednesday 1 January 2020, 06:00 AM

Linda Bryant is a clinical adviser and prescribing pharmacist at Newtown Union Health Service and Porirua Union & Community Health Service, Wellington
As part of our Summer Hiatus we have selected some Practice pieces from throughout the year that you might like to revisit over the summer. This article links through to ELearning
PHARMACOTHERAPY
This article marks the start of a new column provided by the Clinical Advisory Pharmacists Association* based on scenarios that have been presented to prescribing pharmacists working in primary care. Here, the medication review of a frail, older man after a case of pneumonia is discussed
Key points, Life expectancy for frail people is generally less than two years.
For older people and frail people, medicines may have limited long-term benefit i
Kia ora and welcome to New Zealand Doctor Rata Aotearoa
Not a subscriber? Unlock this article by subscribing here.